Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visceral Leishmaniasis”

63 trials

Showing 20 of 63 results

Large-scale testing (Phase 3)Study completedNCT01122771
What this trial is testing

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 602
Post-approval studies (Phase 4)Study completedNCT01032187
What this trial is testing

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 101
Not applicableLooking for participantsNCT04020536
What this trial is testing

Real World Study of Classic Infectious Disease

Who this might be right for
BrucellosesEpidemic Hemorrhagic FeverKala-Azar
Huashan Hospital 10,000
Large-scale testing (Phase 3)Study completedNCT00523965
What this trial is testing

Combination Therapy in Indian Visceral Leishmaniasis

Who this might be right for
Leishmaniasis, Visceral
Banaras Hindu University 624
Not applicableActive Not RecruitingNCT04342715
What this trial is testing

Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
University of York 216
Large-scale testing (Phase 3)Study completedNCT02193022
What this trial is testing

Miltefosine for Children With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Not applicableStudy completedNCT03646981
What this trial is testing

Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Who this might be right for
Leishmaniasis, Visceral
Foundation for Innovative New Diagnostics, Switzerland 704
Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Not applicableStudy completedNCT02148822
What this trial is testing

Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia

Who this might be right for
Visceral LeishmaniasisMalnutrition
Instituto de Salud Carlos III 520
Not applicableEnded earlyNCT06118749
What this trial is testing

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 72
Not applicableStudy completedNCT03269006
What this trial is testing

Improved Case Detection and Vector Control for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 202
Large-scale testing (Phase 3)Study completedNCT03129646
What this trial is testing

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 439
Testing effectiveness (Phase 2)Study completedNCT02431143
What this trial is testing

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 30
Testing effectiveness (Phase 2)Ended earlyNCT00832208
What this trial is testing

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 124
Testing effectiveness (Phase 2)Study completedNCT00370825
What this trial is testing

Combination Chemotherapy for the Treatment of Indian Kala-Azar

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 200
Not applicableStudy completedNCT06977490
What this trial is testing

Human Bioequivalence Study of Amphotericin B Liposome for Injection

Who this might be right for
Invasive Fungal InfectionsNeutropenic FeverVisceral Leishmaniasis
Sichuan Huiyu Pharmaceutical Co., Ltd 42
Post-approval studies (Phase 4)Ended earlyNCT01310738
What this trial is testing

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 378
Testing effectiveness (Phase 2)Study completedNCT01067443
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 151
Testing effectiveness (Phase 2)Study completedNCT00497601
What this trial is testing

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 60
Not applicableActive Not RecruitingNCT03784248
What this trial is testing

Mediterranean Visceral Leishmaniasis With Leishmania Infantum

Who this might be right for
Leishmaniasis
Centre Hospitalier Universitaire de Nice 1,400
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation